Researchers develop expert-backed guidelines for HDFN management
Researchers surveyed experts in fetal medicine and hematology to form a set of recommendations for managing HDFN.
Researchers surveyed experts in fetal medicine and hematology to form a set of recommendations for managing HDFN.
Pregnant patients with multiple antibodies associated with HDFN may be at increased risk of complications including preterm birth.
A technical report summarized current data regarding the use of phototherapy in infants with hyperbilirubinemia, a common sign of HDFN.
A case study reports a severe case of hemolytic disease of the fetus and newborn (HDFN) caused by both anti-D and anti-C antibodies.